Kevin Blansit

Kevin Blansit.jpg
Pre-Doctoral Trainee

Brooks RA, Blansit K, Young-Lin N, Usach I, Chen LM, Yu X, Kapp DS, Chan JK. The economic impact of surgical care for morbidly obese endometrial cancer patients: a nationwide study. Am J Obstet Gynecol. 2016 Apr;214(4):498.e1-6. doi: 10.1016/j.ajog.2015.10.015. Epub 2015 Oct 23.
Chan JK, Gardner AB, Taylor K, Thompson CA, Blansit K, Yu X, Kapp DS. Robotic versus laparoscopic versus open surgery in morbidly obese endometrial cancer patients - a comparative analysis of total charges and complication rates. Gynecol Oncol. 2015 Nov;139(2):300-5. doi: 10.1016/j.ygyno.2015.09.006. Epub 2015 Sep 10.

Fuh KC, Secord AA, Bevis KS, Huh W, ElNaggar A, Blansit K, Previs R, Tillmanns T, Kapp DS, Chan JK. Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients.Gynecol Oncol. 2015 Dec;139(3):413-8. doi: 10.1016/j.ygyno.2015.06.041. Epub 2015 Jul 2.

Chan JK, Gardner AB, Taylor K, Blansit K, Thompson CA, Brooks R, Yu X, Kapp DS.The centralization of robotic surgery in high-volume centers for endometrial cancer patients--a study of 6560 cases in the U.S. Gynecol Oncol. 2015 Jul;138(1):128-32. doi: 10.1016/j.ygyno.2015.04.031. Epub 2015 Apr 28.

Usach I, Blansit K, Chen LM, Ueda S, Brooks R, Kapp DS, Chan JK.Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas. Am J Obstet Gynecol. 2015 Feb;212(2):188.e1-6. doi: 10.1016/j.ajog.2014.08.016. Epub 2014 Aug 18.